黑色素瘤患者的辅助免疫疗法:进展和机遇
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston; Department of Medicine, Brigham and Women's Hospital, Boston; Harvard Medical School, Boston, USA.
ESMO open
|April 16, 2024
概括
高风险黑色素瘤患者在手术后受益于抗编程细胞死亡蛋白1 (PD-1) 免疫疗法. 需要对治疗组合和顺序进行进一步的研究,以获得最佳的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 皮肤黑色素瘤通常可以通过手术治愈,但许多患者的复发风险仍然很高.
- 辅助疗法对于患有高风险黑色素瘤的患者至关重要,即使是患有淋巴结阴性疾病的患者.
研究的目的:
- 审查抗编程细胞死亡蛋白1 (PD-1) 免疫疗法对辅助黑色素瘤治疗的影响.
- 确定在优化高风险黑色素瘤治疗方面的剩余挑战和未来方向.
主要方法:
- 审查当前关于黑色素瘤治疗的文献,重点关注免疫治疗的进展.
- 对抗PD-1治疗在辅助和新辅助环境中的作用的分析.
主要成果:
- 基于抗PD-1的免疫疗法已成为治疗IIB阶段或更高阶段黑色素瘤的标准治疗方法.
- 与单独辅助疗法相比,新辅助疗法显示出更好的结果.
结论:
- 抗PD-1疗法彻底改变了辅助黑色素瘤治疗的方法.
- 对治疗组合 (例如,抗PD-1 + LAG-3),测序和预测标记的进一步研究对于改善高风险黑色素瘤的结果至关重要.
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
01:30Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K